Showing results (221-230 of 307) with videos related to

Sort By:
Pageof 31
Plos One|June 6, 2013
HLA-DRB1 genotypes and the risk of developing anti citrullinated protein antibody (ACPA) positive rheumatoid arthritisNathalie Balandraud, Christophe Picard, Denis Reviron, et al.
RMD Open|July 23, 2024
Diagnosis challenges in inception cohorts in axial spondyloarthritis: the case of the French national DESIR cohortAnna Molto, Chris Serrand, Sandrine Alonso, et al.
Rheumatology (Oxford, England)|August 4, 2023
Evolution of monoclonal gammopathy of undetermined significance in patients treated with JAK inhibitors for rheumatic diseases: data from the MAJIK-SFR registryDéborah Faganello, Anne Bertrand, Pauline Meunier, et al.
Arthritis Research & Therapy|July 20, 2010
Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control studyMélanie Gilson, Laure Gossec, Xavier Mariette, et al.
Seminars in Arthritis and Rheumatism|September 13, 2020
Rituximab for rheumatoid arthritis-associated large granular lymphocytic leukemia, a retrospective case seriesHervé Lobbes, Charles Dervout, Eric Toussirot, et al.
The Journal of Dermatological Treatment|September 15, 2015
Observational case series on adalimumab-induced paradoxical hidradenitis suppurativaMarine Delobeau, Ahlam Abdou, Eve Puzenat, et al.
Rheumatology (Oxford, England)|September 24, 2014
Tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practiceClémentine Fortunet, Yves-Marie Pers, Joseph Lambert, et al.
Clinical and Experimental Rheumatology|October 18, 2016
MRI and serum biomarkers correlate with radiographic features in painful hand osteoarthritisChristian H Roux, Violaine Foltz, Emmanuel Maheu, et al.
Joint Bone Spine|January 1, 2024
Ten-year clinical outcome of recent-onset axial spondyloarthritis: Results from the DESIR inception CohortMaxime Dougados, Chris Serrand, Sandrine Alonso, et al.
Joint Bone Spine|May 31, 2020
Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020Christophe Richez, René-Marc Flipo, Francis Berenbaum, et al.
Pageof 31